Sunday, December 24, 2023

Oral parenteral ketorolac therapy is limited to 5 days of therapy due to an increased risk of.. Renal impairment .Gastro intestinal bleeding/ perforation



Oral parenteral ketorolac therapy is limited to 5 days of therapy due to an increased risk of

  • A. Renal impairment
  • B. Gastro intestinal bleeding/ perforation
  • C. Liver failure
  • D. CNS disturbances
  • E. A and B.

The answer is (E) A and B.

Oral and parenteral ketorolac therapy is limited to 5 days of therapy due to an increased risk of renal impairment and gastrointestinal bleeding/perforation.

Other side effects of ketorolac include:

  • CNS disturbances (e.g., headache, dizziness, drowsiness).
  • Liver failure (rare).
  • Cardiovascular events (e.g., myocardial infarction, stroke).
  • Hematologic events (e.g., neutropenia, thrombocytopenia).
  • Hypersensitivity reactions.
However, the risk of these side effects is generally low when ketorolac is used for short periods of time (5 days or less).

It is important to note that ketorolac is not recommended for everyone. It should be used with caution in patients with a history of gastrointestinal ulcers, renal impairment, or bleeding disorders. It is also important to avoid using ketorolac with other NSAIDs, as this can increase the risk of side effects.

If you are taking ketorolac, it is important to be aware of the risks and benefits of the medication. You should also talk to your doctor about how long to take ketorolac for.